220
W. Le6ason et al. / Journal of Organometallic Chemistry 619 (2001) 218–225
1492s, 1453s, 1414s, 1361m, 1229m, 1159m, 1102m,
957m, 849s, 767m, 740m, 558s, 426w. UV–vis (103
cm−1) (mmol dm3mol−1 cm−1) (dmf) 26 850 (sh, 8067).
431m, 302m. UV–vis (103 cm−1) (mmol dm3 mol−1
cm−1) (dmf) 24 440 (960).
2.11. [Mo(CO)4(xyte)]
2.8. [Mn(CO)3Cl(xyte)]
A suspension of [Mo(CO)4(piperidine)2] (0.2 g, 0.53
mmol) in CH2Cl2 (10 ml) was treated with the ligand
(0.21 g, 0.53 mmol) in CH2Cl2 (2 ml) and the mixture
refluxed for 1 h. The solution was cooled to r.t. and
hexane was added. The yellow powder was separated
by filtration and dried in vacuo (0.227 g 72%). (Found:
C, 26.3; H, 2.2. C14H14MoO4Te2·CH2Cl2 requires C,
26.4; H, 2.4%). FAB mass spectrum: m/z=598; calc.
To a solution of [Mn(CO)5Cl] (0.1 g, 0.43 mmol) in
CH2Cl2 (5 ml) was added a solution of xyte (0.17 g,
0.43 mmol) in CH2Cl2 (5 ml), and the mixture stirred
for 24 h at r.t. Filtration afforded an orange powder
(0.168 g, 69%). (Found: C, 27.5; H, 2.5.
C15H14ClMnO3Te2 requires C, 27.7; H, 2.5%). ES+
mass
spectrum:
m/z
569,
559;
calc.
for
[C13H ClMnO1330Te2]+ 568, [C12H ClMnO3130Te2]+
for [C14H MoO1430Te2]+ 604. 1H-NMR (CDCl3)
35
14
35
11
98
14
553. 1H-NMR (CDCl3) 1.7(s), 2.28(s), 2.3(s), 2.48(s),
3.43(d), 3.69(d), 3.96(d), 4.11(d), 4.80(d), 5.15(d),
5.49(d), 7.0–7.3(m). 13C{1H}-NMR (CDCl3) 220–215
(br, CO), 135.9, 131.6, 129.0, 13.4, 12.8, 12.5, 11.5,
−7.1, −7.3, −7.6, −8.1. IR (cm−1) (CsI disc)
3022w, 2922w, 2016s, 1932s, 1903s, 1576m, 1487s,
1446s, 1421s, 1359m, 1228m, 1146m, 1109m, 1059m,
856m, 762s, 669s, 630s, 613s, 532m, 512m, 280s. CHCl3
solution 2022(s), 1949(m), 1916(m).
2.27(s), 2.25(sh), 3.7–3.8(m), 5.4(s CH2Cl2), 7.0–
2.25(m). 13C{1H}-NMR (CDCl3) 214.7, 214.9, 211.8,
210.0, 209.8, 136.4, 131.0, 128.1, 23.0, 22.8, −8.1,
−8.5. IR (cm−1) (CsI disc) 2930w, 2850w, 2013vs,
1904vs, 1844vs, 1627m, 1488m, 1455m, 1409m, 1363w,
1219s, 1200w, 1146w, 1135m, 1057m, 950s, 837s, 759s,
622s, 584s, 530m, 478m, 394s, 379s. CHCl3 solution
2022m, 1925vs, 1907vs, 1871s.
2.12. [W(CO)4(xyte)]
2.9. [Ru(xyte)2Cl2]
To a suspension of [W(CO)4(piperidine)2] (0.1 g,
0.215 mmol) in THF (5 ml) was added a solution of the
ligand (0.84 g, 0.215 mmol) in THF (5 ml) and the
reaction mixture refluxed for 24 h, and then stirred at
r.t. for 24 h. The solution was concentrated to 5 ml in
vacuo, hexane added (10 ml), and the product filtered
off. It was washed with hexane and dried in vacuo (0.04
A solution of [Ru(dmf)6][CF3SO3]3 (0.15 g, 0.15
mmol), xyte (0.118 g, 0.3 mmol), and LiCl (0.039 g,
0.91 mmol) were refluxed together in ethanol (15 ml)
for 4 h. The solvent was removed in vacuo and the
residue extracted with CH2Cl2, filtered, and the solvent
reduced to 5 ml. Diethyl ether (20 ml) was added, and
the product isolated as a brown powder, which was
recrystallised from CHCl3–hexane (0.085 g, 57%).
(Found: C, 21.2, H, 2.6; C20H28Cl2RuTe4.3CHCl3 re-
quires C, 21.1; H, 2.4%). ES+ MS m/z 956; calc. for
g,
C14H14O4Te2W.0.5THF requires C, 26.6; H, 2.5%).
FAB mass spectrum: m/z=688; calc. for
27%)
(Found:
C,
26.1;
H,
2.5;.
[C14H14O4130Te1284W]+ 690. 1H-NMR (CDCl3) 2.39(s),
2.36(s), 3.8–3.95(m), 7.0–7.3(m). 13C{1H}-NMR
(CDCl3) 204.8, 204.2, 202.7, 202.4, 201.8, 136.5, 136.0,
131.0, 128.1, 23.7, 23.0, −6.0, −6.5. IR (cm−1) (CsI
disc) 2922m, 2854w, 2006vs, 1870vs, 1839vs, 1490m,
1451m, 1438m, 1407m, 1363m, 1221m, 1137m, 1104m,
1053m, 857m, 838m, 764s, 605s, 577s, 387s. CHCl3
solution 2016s, 1914vs, 1898vs, 1866s.
[C20H Cl1201Ru130Te4]+ 959. IR (cm−1) (CsI disc)
35
28
3013w, 2921w, 1668m, 1629m, 1574m, 1488s, 1449s,
1407s, 1363m, 1098m, 1047m, 838s, 760s, 561m, 517m,
271m. UV–vis (103 cm−1) (dmf)(mmol dm3 mol−1 cm−1
)
27 840 (7374), 22 523 (2530).
2.10. [Os(xyte)2Cl2]
A mixture of [Os(dmso)4Cl2] (0.1 g, 0.17 mmol) and
xyte (0.136 g, 0.35 mmol) in MeCN (15 ml) was
refluxed for 3 h. The solution was cooled and filtered,
and the solvent removed in vacuo. The residue was
extracted with CH2Cl2, concentrated to 5 ml, and di-
ethyl ether (20 ml) added to afford an orange powder
(0.066 g, 36%). (Found: C, 22.9; H, 2.5;
C10H14Cl2OsTe4 requires C, 22.7; H, 2.5%.). ES+ MS
2.13. X-ray structures of [Mn(CO)3Cl(xyte)] and
[W(CO)4(xyte)]
Details of the crystallographic data collection and
refinement parameters are given in Table 1. Crystals of
the former were obtained by diffusion of hexane into an
acetone solution of the complex, and crystals of the
tungsten complex by cooling a CHCl3 solution in a
freezer. Data collection used a Rigaku AFC7S four-cir-
cle diffractometer (T=150 K) with graphite monochro-
m/z 1049, 1003, 969; calc. for [C20H Cl1292Os130Te4]+
35
28
1050, [C19H Cl192Os130Te4]+ 1000, [C19H Os130Te4]+
35
25
192
25
965. IR (cm−1) (CsI disc) 3013w, 2921w, 1489s, 1450s,
1414s, 1363m, 1078s, 1015m, 844m, 765s, 683m, 562m,
mated Mo–Ka radiation (u=0.71073 A). Structure
,
solution and refinement were routine [14–16]. Selected